PTK6 and breast cancer: In this study, we report for the first time that inhibition of PTK6 induces apoptotic cell death of Her2+ breast cancer cells that are relatively resistant to Lapatinib at baseline or after continuous treatment in the presence of this Her2 tyrosine kinase inhibitor (TKI).